皓宸医疗（002622）1月7日主力资金净买入106.35万元

Core Viewpoint - The stock of Haocen Medical (002622) has shown a decline in price and performance metrics, indicating potential challenges in the company's financial health and market position [1][2]. Group 1: Stock Performance - As of January 7, 2026, Haocen Medical's stock closed at 3.04 yuan, down 2.88%, with a turnover rate of 4.11% and a trading volume of 344,900 hands, amounting to a transaction value of 106 million yuan [1]. - The net inflow of main funds on January 7 was 1.06 million yuan, accounting for 1.01% of the total transaction value, while retail investors experienced a net outflow of 2.87 million yuan, representing 2.71% of the total [1]. Group 2: Financial Metrics - Haocen Medical's total market capitalization is 25.54 billion yuan, with a net asset value of 4.11 billion yuan and a net profit of -26.41 million yuan, ranking 42nd in the industry [2]. - The company's net profit margin stands at -5.89%, and the return on equity (ROE) is -6.86%, indicating financial difficulties compared to the industry average [2]. - For the first three quarters of 2025, the company's main revenue was 527 million yuan, a year-on-year decrease of 17.03%, with a net profit decline of 295.68% [2]. Group 3: Operational Insights - Haocen Medical primarily engages in oral medical services and the research, production, and sales of permanent magnet switches and high/low voltage switchgear [2].